Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.

导出原文传递

翻译打印收藏纠错

作者： Paloma,Campo ^[1] ; Gregorio,Soto Campos ^[2] ; Ana,Moreira ^[3] ; Santiago,Quirce ^[4] ; Alicia,Padilla-Galo ^[5] ; Eva,Martínez-Moragón ^[6] ; Aizea,Mardones ^[7] ; Ignacio,Dávila ^[8]

作者单位： Allergy Unit, IBIMA-Regional University Hospital of Málaga, ARADyAL, Málaga, Spain. ^[1] Pneumology and Allergy Unit, University Hospital of Jerez, Cádiz, Spain. ^[2] Novartis Farmacéutica, Barcelona, Spain. ^[3] Department of Allergy, La Paz Hospital Institute for Health Research (IdiPAZ), Centro de investigación en red de enfermedades respiratorias (CIBERES), Madrid, Spain. ^[4] Pneumology Unit, Costa del Sol Hospital, Marbella, Málaga, Spain. ^[5] Pneumology Service, University Hospital Doctor Peset, Valencia, Spain. ^[6] Pneumology Service, University Hospital Basurto, Bilbao, Spain. ^[7] Allergy Service, University Hospital of Salamanca and Institute for Biomedical Research of Salamanca (IBSAL), Biomedical and Diagnosis Science Department, Salamanca University School of Medicine, Salamanca, Spain. ^[8]

主题词抗哮喘药(Anti-Asthmatic Agents);哮喘(Asthma);人类(Humans);治疗结果(Treatment Outcome)

DOI 10.1111/all.14668

PMID 33220106

发布时间 2021-06-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交